 | • レポートコード：D0804-00646 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、抗がん剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗がん剤の種類別市場規模（細胞毒性薬（アルキル化剤、代謝拮抗薬）、標的薬（モノクローナル抗体、チロシンキナーゼ阻害剤）、ホルモン薬）、用途別市場規模（肺がん、乳がん、白血病、大腸がん）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：F. Hoffmann-La Roche Ltd、AstraZeneca、Novartis AG、Eli Lilly and Company、Bayer AG、CELGENE CORPORATION、Merck & Co.、Amgen Inc、Pfizer Inc、Takeda Pharmaceutical Company Limited ・地域別グローバル市場分析 2015年-2020年 ・抗がん剤の北米市場（アメリカ、カナダ、メキシコ） ・抗がん剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗がん剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗がん剤の南米市場（ブラジル、アルゼンチン） ・抗がん剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：細胞毒性薬（アルキル化剤、代謝拮抗薬）、標的薬（モノクローナル抗体、チロシンキナーゼ阻害剤）、ホルモン薬 ・用途別分析：肺がん、乳がん、白血病、大腸がん ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Anticancer Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.5% in the forecast period of 2020 to 2025 and will expected to reach USD 99610 million by 2025, from USD 86710 million in 2019.
The Anticancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Anticancer Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Anticancer Drugs market has been segmented into
Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
Hormonal Drugs
By Application, Anticancer Drugs has been segmented into:
Lung Cancer
Breast Cancer
Leukemia
Colorectal Cancer
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anticancer Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Anticancer Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anticancer Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Anticancer Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Anticancer Drugs Market Share Analysis
Anticancer Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anticancer Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anticancer Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Anticancer Drugs are:
F. Hoffmann-La Roche Ltd
AstraZeneca
Novartis AG
Eli Lilly and Company
Bayer AG
CELGENE CORPORATION
Merck & Co.
Amgen Inc
Pfizer Inc
Takeda Pharmaceutical Company Limited
Among other players domestic and global, Anticancer Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anticancer Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anticancer Drugs, with price, sales, revenue and global market share of Anticancer Drugs in 2018 and 2019.
Chapter 3, the Anticancer Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anticancer Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Anticancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Anticancer Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Anticancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anticancer Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
1.2.3 Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
1.2.4 Hormonal Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Anticancer Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Leukemia
1.3.5 Colorectal Cancer
1.4 Overview of Global Anticancer Drugs Market
1.4.1 Global Anticancer Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 F. Hoffmann-La Roche Ltd
2.1.1 F. Hoffmann-La Roche Ltd Details
2.1.2 F. Hoffmann-La Roche Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 F. Hoffmann-La Roche Ltd SWOT Analysis
2.1.4 F. Hoffmann-La Roche Ltd Product and Services
2.1.5 F. Hoffmann-La Roche Ltd Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AstraZeneca SWOT Analysis
2.2.4 AstraZeneca Product and Services
2.2.5 AstraZeneca Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis AG SWOT Analysis
2.3.4 Novartis AG Product and Services
2.3.5 Novartis AG Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eli Lilly and Company
2.4.1 Eli Lilly and Company Details
2.4.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Eli Lilly and Company SWOT Analysis
2.4.4 Eli Lilly and Company Product and Services
2.4.5 Eli Lilly and Company Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bayer AG
2.5.1 Bayer AG Details
2.5.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bayer AG SWOT Analysis
2.5.4 Bayer AG Product and Services
2.5.5 Bayer AG Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 CELGENE CORPORATION
2.6.1 CELGENE CORPORATION Details
2.6.2 CELGENE CORPORATION Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 CELGENE CORPORATION SWOT Analysis
2.6.4 CELGENE CORPORATION Product and Services
2.6.5 CELGENE CORPORATION Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck & Co.
2.7.1 Merck & Co. Details
2.7.2 Merck & Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merck & Co. SWOT Analysis
2.7.4 Merck & Co. Product and Services
2.7.5 Merck & Co. Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Amgen Inc
2.8.1 Amgen Inc Details
2.8.2 Amgen Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Amgen Inc SWOT Analysis
2.8.4 Amgen Inc Product and Services
2.8.5 Amgen Inc Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer Inc
2.9.1 Pfizer Inc Details
2.9.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer Inc SWOT Analysis
2.9.4 Pfizer Inc Product and Services
2.9.5 Pfizer Inc Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Takeda Pharmaceutical Company Limited
2.10.1 Takeda Pharmaceutical Company Limited Details
2.10.2 Takeda Pharmaceutical Company Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Takeda Pharmaceutical Company Limited SWOT Analysis
2.10.4 Takeda Pharmaceutical Company Limited Product and Services
2.10.5 Takeda Pharmaceutical Company Limited Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Anticancer Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Anticancer Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Anticancer Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Anticancer Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Anticancer Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Anticancer Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Anticancer Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Anticancer Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Anticancer Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Anticancer Drugs Sales and Growth Rate (2015-2020)
4.5 South America Anticancer Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Anticancer Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Anticancer Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Anticancer Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Anticancer Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Anticancer Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Anticancer Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Anticancer Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Anticancer Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Anticancer Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Anticancer Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Anticancer Drugs Sales and Growth Rate (2015-2020)
6.3 UK Anticancer Drugs Sales and Growth Rate (2015-2020)
6.4 France Anticancer Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Anticancer Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Anticancer Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Anticancer Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Anticancer Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Anticancer Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Anticancer Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Anticancer Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Anticancer Drugs Sales and Growth Rate (2015-2020)
7.5 India Anticancer Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Anticancer Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Anticancer Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Anticancer Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Anticancer Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Anticancer Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Anticancer Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Anticancer Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Anticancer Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Anticancer Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Anticancer Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Anticancer Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Anticancer Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Anticancer Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Anticancer Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Anticancer Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Anticancer Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Anticancer Drugs Price by Type (2015-2020)
11 Global Anticancer Drugs Market Segment by Application
11.1 Global Anticancer Drugs Sales Market Share by Application (2015-2020)
11.2 Global Anticancer Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Anticancer Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Anticancer Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Anticancer Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Anticancer Drugs Market Forecast (2021-2025)
12.2.2 Europe Anticancer Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Anticancer Drugs Market Forecast (2021-2025)
12.2.4 South America Anticancer Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Anticancer Drugs Market Forecast (2021-2025)
12.3 Anticancer Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Anticancer Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Anticancer Drugs Market Share Forecast by Type (2021-2025)
12.4 Anticancer Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Anticancer Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Anticancer Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Anticancer Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anticancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anticancer Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 8. F. Hoffmann-La Roche Ltd Anticancer Drugs Major Business
Table 9. F. Hoffmann-La Roche Ltd Anticancer Drugs Total Revenue (USD Million) (2017-2018)
Table 10. F. Hoffmann-La Roche Ltd SWOT Analysis
Table 11. F. Hoffmann-La Roche Ltd Anticancer Drugs Product and Services
Table 12. F. Hoffmann-La Roche Ltd Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 14. AstraZeneca Anticancer Drugs Major Business
Table 15. AstraZeneca Anticancer Drugs Total Revenue (USD Million) (2017-2018)
Table 16. AstraZeneca SWOT Analysis
Table 17. AstraZeneca Anticancer Drugs Product and Services
Table 18. AstraZeneca Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 20. Novartis AG Anticancer Drugs Major Business
Table 21. Novartis AG Anticancer Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Novartis AG SWOT Analysis
Table 23. Novartis AG Anticancer Drugs Product and Services
Table 24. Novartis AG Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 26. Eli Lilly and Company Anticancer Drugs Major Business
Table 27. Eli Lilly and Company Anticancer Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Eli Lilly and Company SWOT Analysis
Table 29. Eli Lilly and Company Anticancer Drugs Product and Services
Table 30. Eli Lilly and Company Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 32. Bayer AG Anticancer Drugs Major Business
Table 33. Bayer AG Anticancer Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Bayer AG SWOT Analysis
Table 35. Bayer AG Anticancer Drugs Product and Services
Table 36. Bayer AG Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. CELGENE CORPORATION Basic Information, Manufacturing Base and Competitors
Table 38. CELGENE CORPORATION Anticancer Drugs Major Business
Table 39. CELGENE CORPORATION Anticancer Drugs Total Revenue (USD Million) (2017-2018)
Table 40. CELGENE CORPORATION SWOT Analysis
Table 41. CELGENE CORPORATION Anticancer Drugs Product and Services
Table 42. CELGENE CORPORATION Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 44. Merck & Co. Anticancer Drugs Major Business
Table 45. Merck & Co. Anticancer Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Merck & Co. SWOT Analysis
Table 47. Merck & Co. Anticancer Drugs Product and Services
Table 48. Merck & Co. Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 50. Amgen Inc Anticancer Drugs Major Business
Table 51. Amgen Inc Anticancer Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Amgen Inc SWOT Analysis
Table 53. Amgen Inc Anticancer Drugs Product and Services
Table 54. Amgen Inc Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 56. Pfizer Inc Anticancer Drugs Major Business
Table 57. Pfizer Inc Anticancer Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Pfizer Inc SWOT Analysis
Table 59. Pfizer Inc Anticancer Drugs Product and Services
Table 60. Pfizer Inc Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 62. Takeda Pharmaceutical Company Limited Anticancer Drugs Major Business
Table 63. Takeda Pharmaceutical Company Limited Anticancer Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Takeda Pharmaceutical Company Limited SWOT Analysis
Table 65. Takeda Pharmaceutical Company Limited Anticancer Drugs Product and Services
Table 66. Takeda Pharmaceutical Company Limited Anticancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Anticancer Drugs Sales by Manufacturer (2018-2019) (MT)
Table 68. Global Anticancer Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Anticancer Drugs Sales by Regions (2015-2020) (MT)
Table 70. Global Anticancer Drugs Sales Market Share by Regions (2015-2020)
Table 71. Global Anticancer Drugs Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Anticancer Drugs Sales by Countries (2015-2020) (MT)
Table 73. North America Anticancer Drugs Sales Market Share by Countries (2015-2020)
Table 74. North America Anticancer Drugs Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Anticancer Drugs Revenue Market Share by Countries (2015-2020)
Table 76. Europe Anticancer Drugs Sales by Countries (2015-2020) (MT)
Table 77. Europe Anticancer Drugs Sales Market Share by Countries (2015-2020)
Table 78. Europe Anticancer Drugs Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Anticancer Drugs Sales by Regions (2015-2020) (MT)
Table 80. Asia-Pacific Anticancer Drugs Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Anticancer Drugs Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Anticancer Drugs Sales by Countries (2015-2020) (MT)
Table 83. South America Anticancer Drugs Sales Market Share by Countries (2015-2020)
Table 84. South America Anticancer Drugs Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Anticancer Drugs Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Anticancer Drugs Sales by Countries (2015-2020) (MT)
Table 87. Middle East & Africa Anticancer Drugs Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Anticancer Drugs Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Anticancer Drugs Revenue Market Share by Countries (2015-2020)
Table 90. Global Anticancer Drugs Sales by Type (2015-2020) (MT)
Table 91. Global Anticancer Drugs Sales Share by Type (2015-2020)
Table 92. Global Anticancer Drugs Revenue by Type (2015-2020) (USD Million)
Table 93. Global Anticancer Drugs Revenue Share by Type (2015-2020)
Table 94. Global Anticancer Drugs Sales by Application (2015-2020) (MT)
Table 95. Global Anticancer Drugs Sales Share by Application (2015-2020)
Table 96. Global Anticancer Drugs Sales Forecast by Regions (2021-2025) (MT)
Table 97. Global Anticancer Drugs Market Share Forecast by Regions (2021-2025)
Table 98. Global Anticancer Drugs Sales Forecast by Type (2021-2025) (MT)
Table 99. Global Anticancer Drugs Market Share Forecast by Type (2021-2025)
Table 100. Global Anticancer Drugs Sales Forecast by Application (2021-2025)
Table 101. Global Anticancer Drugs Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Anticancer Drugs Picture
Figure 2. Global Sales Market Share of Anticancer Drugs by Type in 2019
Figure 3. Cytotoxic Drugs (Alkylating Agents, and Antimetabolites) Picture
Figure 4. Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors) Picture
Figure 5. Hormonal Drugs Picture
Figure 6. Anticancer Drugs Sales Market Share by Application in 2018
Figure 7. Lung Cancer Picture
Figure 8. Breast Cancer Picture
Figure 9. Leukemia Picture
Figure 10. Colorectal Cancer Picture
Figure 11. Global Anticancer Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Anticancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Anticancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Anticancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Anticancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Anticancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Anticancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Anticancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Anticancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Anticancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Anticancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Anticancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Anticancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Anticancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Anticancer Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Anticancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Anticancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Anticancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Anticancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Anticancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Anticancer Drugs Sales Market Share by Manufacturer in 2019
Figure 32. Global Anticancer Drugs Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Anticancer Drugs Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Anticancer Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Anticancer Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 37. Global Anticancer Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Anticancer Drugs Revenue Market Share by Regions (2015-2020)
Figure 39. Global Anticancer Drugs Revenue Market Share by Regions in 2018
Figure 40. North America Anticancer Drugs Sales and Growth Rate (2015-2020)
Figure 41. Europe Anticancer Drugs Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Anticancer Drugs Sales and Growth Rate (2015-2020)
Figure 43. South America Anticancer Drugs Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Anticancer Drugs Sales and Growth Rate (2015-2020)
Figure 45. North America Anticancer Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Anticancer Drugs Sales Market Share by Countries (2015-2020)
Figure 47. North America Anticancer Drugs Sales Market Share by Countries in 2018
Figure 48. North America Anticancer Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Anticancer Drugs Revenue Market Share by Countries in 2018
Figure 50. United States Anticancer Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 51. Canada Anticancer Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 52. Mexico Anticancer Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 53. Europe Anticancer Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Anticancer Drugs Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Anticancer Drugs Revenue Market Share by Countries in 2019
Figure 56. Germany Anticancer Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 57. UK Anticancer Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 58. France Anticancer Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 59. Russia Anticancer Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 60. Italy Anticancer Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 61. Asia-Pacific Anticancer Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Anticancer Drugs Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Anticancer Drugs Revenue Market Share by Regions 2019
Figure 64. China Anticancer Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 65. Japan Anticancer Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 66. Korea Anticancer Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 67. India Anticancer Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 68. Southeast Asia Anticancer Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 69. South America Anticancer Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Anticancer Drugs Sales Market Share by Countries in 2019
Figure 71. South America Anticancer Drugs Revenue Market Share by Countries in 2019
Figure 72. Brazil Anticancer Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 73. Argentina Anticancer Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 74. Middle East and Africa Anticancer Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Anticancer Drugs Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Anticancer Drugs Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Anticancer Drugs Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Anticancer Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 79. Egypt Anticancer Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 80. Turkey Anticancer Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 81. South Africa Anticancer Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 82. Global Anticancer Drugs Sales and Growth Rate (2021-2025) (MT)
Figure 83. Global Anticancer Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Anticancer Drugs Market Forecast (2021-2025) (MT)
Figure 85. Europe Sales Anticancer Drugs Market Forecast (2021-2025) (MT)
Figure 86. Asia-Pacific Sales Anticancer Drugs Market Forecast (2021-2025) (MT)
Figure 87. South America Sales Anticancer Drugs Market Forecast (2021-2025) (MT)
Figure 88. Middle East & Africa Sales Anticancer Drugs Market Forecast (2021-2025) (MT)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
非小細胞肺がん治療薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Drugs for Non-small Cell Lung Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Drugs fo…- VEGF阻害薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The VEGF Inhibitor Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- VEGF / VEGFR阻害薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The VEGF/VEGFR Inhibitor Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 胆管がん治療薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Bile Duct Cancer Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bile Duct Cancer Drugs…
- 胆管がん治療薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Bile Duct Cancer Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bile Duct Cancer Drugs…